A recent study highlights a significant rise in AI-related clinical trials, particularly in the US and China, with increasing mentions of technologies like machine learning and large language models. The research suggests that a hybrid human-AI approach for screening trial records is promising, though improvements in trial reporting and interaction definitions are needed for better accuracy.